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REVIEW
Abstract: Schizophrenia, once considered a psychological malady devoid of any organic
brain substrate, has been the focus of intense neuroimaging research. Findings reveal mild but
generalized tissue loss as well as more selective focal loss. It is unclear whether these
abnormalities reflect neurodevelopmental or neurodegenerative processes, or some combination
of each; current evidence favors a preponderance of neurodevelopmental abnormalities. The
pattern of brain abnormalities is also influenced by environmental and genetic risk factors, as
well as by the course (and possibly even treatment) of this illness. These findings are described
in this article.
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Introduction
Schizophrenia is a major mental disorder most often characterized by functional
impairment and by the presentation, persistence, and severity of symptoms (Table 1).
It is considered as a brain disorder (Jones and Buckley 2003; McClure and Lieberman
2003). Although its fundamental pathobiology remains elusive, neuroimaging studies
provide compelling evidence of (subtle) abnormalities of cerebral structure and
function in patients with schizophrenia (McCarley et al 1999; Wright et al 2000;
Flashman and Green 2004). This article reviews our understanding of the nature and
extent of structural brain abnormalities in schizophrenia.
The origins of schizophrenia: pathophysiological
speculations
An argument has raged back and forth as to whether the brain abnormalities in
schizophrenia are either neurodegenerative or neurodevelopmental in origin
(Weinberger and Marenco 2003). The neurodevelopmental view held ascendancy
until several recent studies which have now provided evidence of progressive brain
deterioration (DeLisi et al 1997; Vita et al 1997; Mathalon et al 2001; Thompson et
al 2001; Cahn et al 2002; Ho, Andreasen, et al 2003; Sporn et al 2003). Current
theories concerning the origins of schizophrenia suggest these structural neuroimaging
changes are evidence of a neurodevelopmental basis for schizophrenia, arising from
early noxious events (intra utero and perhaps also in early childhood/adolescence)
that are either genetic or environmental or involve some combination of the two
types of events (Buckley et al 2003; Weinberger and Marenco 2003). While this
neurodevelopmental model has held ascendancy in conceptualizing the onset and
cause(s) of schizophrenia, there is also evidence of progressive brain changes
(neurodegenerative processes) in some patients with schizophrenia. There is evidence
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that these changes are present (to a similar extent and
magnitude) in first-episode schizophrenia patients. A
summary of recent neuroimaging findings in populations
with first-episode schizophrenia is provided in Table 2. More
recent, neuroimaging studies have tracked the course of these
brain changes and they show a deterioration in brain
structure with compelling evidence now of loss of cortical
tissue and progressive ventricular enlargement (DeLisi et
al 1997; Mathalon et al 2001; Ho, Andreasen, et al 2003;
Kasai et al 2003b; Sporn et al 2003). These findings have
led some to recast the neurodevelopment versus neuro-
degeneration dichotomy essentially as a two-stage
pathogenic trajectory (Church et al 2002; McClure and
Lieberman 2003). In such a schema, it is proposed that some
noxious event causes initial neurodevelopmental cortical
impairment. This impaired cortical substrate confers
susceptibility thereafter to the later emergence of neuro-
degenerative processes. Thus, this may represent an
interactive process between neurodevelopmental vulner-
ability and progressive deterioration with neurotoxicity
(Mathalon, Rapaport, et al 2003). The emergence of early-
onset dementia in patients with Down’s syndrome provides
the prototype for this pathogenic model. In this regard, a
recent study by Teipel and colleagues (2003) reported
substantial hippocampal and corpus callosal loss in
nondemented patients with Down’s syndrome. It is plausible
that a neurodevelopmental–neurodegenerative interaction
such as this may also account for the pattern of brain changes
seen in schizophrenia.
Another important consideration is whether specific
brain regions are involved in schizophrenia or whether there
is global involvement. Some have argued that schizophrenia
is a disorder of neural dysconnectivity (Andreasen 1999)
and that the brain changes reflect widespread failure of
neural connections. The post-mortem disturbances in
cortical synaptic formation, as well as mitochondrial
abnormalities that may underlie cell membrane
(phospholipid) development, are consistent with this view
of schizophrenia (Davis and Haroutunian 2003). As I review
herein neuroimaging findings from studies in schizophrenia,
I will attempt to evaluate the relevance for each of these
aspects of our understanding of schizophrenia.
Methodological considerations
In advance of reviewing available studies, some
consideration is necessary of the methodological issues that
prevail in this literature. First, structural neuroimaging
research in schizophrenia is a mammoth undertaking. There
are several important technical issues that affect both the
quality of the study and its comparability with other
schizophrenia imaging studies. These are listed in Table 3.
Methodological issues related to clinical aspects of
schizophrenia are also of importance. Diagnosis is a major
consideration. This may be most clear in patients with
chronic illness. On the other hand, well characterized
schizophrenia occurring early in childhood tends to a severe
and more progressive illness associated with more
Table 1 Core characteristics of schizophrenia
￿ Delusions
- Persecutory
- Referential
- Guilt
- Religious
- Nihilism
- Somatic
- Bizarre
￿ Hallucinations
- Auditory
- Visual
- Somatic
- Olfactory
￿ Thought disorder
- Loosening of association
- Neologisms
- Word salad
￿ Negative symptoms
- Apathy
- Avolition
- Amotivation
- Neglect
- Alogia
￿ Cognitive impairment
- Memory
- Attention and concentration
￿ Impairment of insight into illness
￿ Functional impairment
- Vocational
- Social
- Interpersonal
NOTE: There is no single, pathognomonic feature of schizophrenia. The
constellation of symptoms is otherwise not attributable to mood disorder,
substance abuse, or any organic brain disorder.
Table 2 Overview of structural neuroimaging abnormalities in
schizophrenia
￿ Generalized
- Cortical tissue loss
- Lateral ventricular enlargement
- Third ventricle enlargement
￿ Regional
- Smaller thalamus
- Enlarged caudate nucleus
- Smaller temporal lobes
- Reversed cerebral asymmetriesNeuropsychiatric Disease and Treatment 2005:1(3) 195
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pronounced brain changes (Thompson et al 2001).
Comorbid substance abuse can also be a major confounder
in neuroimaging studies. Patients with alcohol comorbidity
exhibit a more complex pattern of brain abnormalities during
neuroimaging studies (Mathalon, Pfefferbaum, et al 2003).
While many studies specifically exclude patients with recent
substance abuse, it may well be the case that patients with
substantial substance abuse early on in their illness are still
included. Additionally, although other aspects of the prior
history such as head injury may go undetected, these may
still be of direct relevance to the brain imaging examination
(Buckley et al 1993). It is also becoming more apparent
that the medications patients take can affect the
measurements of brain structures, especially in the basal
ganglia (Arango et al 2003; Lang et al 2004).
It is also important to appreciate that imaging research
requires large patient samples. This is particularly relevant
for studies examining symptomatic or genetic correlates of
brain abnormalities. Additionally, since so much more
information is gleaned from sequential MRI assessments,
studies that are able to retain their patient population across
time are particularly helpful. The attrition of subjects from
longitudinal studies makes this very difficult research
indeed.
Historical context
Johnstone and colleagues (1976) first demonstrated brain
abnormalities on CT scans in patients with schizophrenia.
This finding of enlarged ventricles is still the most consistent
and reproducible finding in neuroimaging studies of
schizophrenia (McCarley et al 1999). Cortical sulcal
prominence, a less presumptive term than either cortical
atrophy or hypoplasia, is another early finding for CT that
was again confirmed as a reproducible finding in subsequent
MRI studies (Friedman et al 1991; McCarley et al 1999;
Flashman and Green 2004). However, it soon became
apparent that these abnormalities were subtle in extent and
were neither universally reproducible across studies nor
specific to schizophrenia alone (Table 4). As alluded to
above, patient characteristics (age, sex, chronicity of illness,
site – eg, state facility versus veterans’ hospitals) exert a
powerful influence on the prevalence and pattern of the
observed brain abnormalities (for discussion, see Lauriello
et al 1997; McCarley et al 1999) (Table 3). These factors
are critical to take into account when evaluating the available
literature. A succinct review of this literature is provided
here.
Qualitative and generalized
brain abnormalities:
neurodevelopmental anomalies
The availability of high resolution MRI and the capacity
for sequential imaging has been a real advantage in exploring
the relative effect of neurodevelopmental versus neuro-
degenerative processes in schizophrenia. Although the brain
changes are subtle, several studies have reported high rates
of neurodevelopmental abnormalities on MRI examination.
These include corpus callosal agenesis, cavum septum
pellucidum, and hypoplasias/heterotopias, which are thought
to be of etiopathologic significance (Andreasen et al 1990;
DeLisi et al 1993; O’Callaghan et al 1995; Woodruff et al
1995; McCarley et al 1999; Lieberman et al in press). Several
groups have described failure of fusion of the leaflet
separating the lateral ventricles, cavum septum pellucidum
(CSP), in patients with schizophrenia. Estimates vary widely
(2%–58% in imaging studies); when only large CSP was
considered in one study this abnormality was still found in
some 20% of patients (Nopoulos et al 1997). Dysgenesis or
agenesis of the corpus callosum, whether evident
qualitatively or through measurement, has been observed
in a minority of patients (Woodruff et al 1995). Other
findings that can be seen on qualitative evaluation include
porencephalic cysts, micro- and macrogyria, white matter
heterotopias (gray matter neurons that are developmentally
misplaced within cortical white matter tracts), and the so-
called unidentified bright objects (UBOs), probably related
to microvascular ischemia. Many of these findings are of
Table 3 Methodological and patient population considerations
in brain imaging studies of schizophrenia
￿ Technical parameters
- Scanner type and strength (1.5T vs 3T)
- Image sequence
- Slice thickness
- Post-processing techniques
- Atlas or reference points for anatomical demarcation
- Procedure used to determine measurements (automated vs
semiautomated vs receiver operated)
￿ Illness parameters
- Accuracy of diagnosis
- Stage of illness (prodromal, first episode, multiepisode, chronic-
refractory)
- Comorbidities (eg, substance abuse, medical illness)
- Medications (antipsychotic naive or medicated, choice of
medication)
￿ Patient population parameters
- Age
- Gender composition
- Matching to control subjects
- Extent of patient attrition in longitudinal studiesNeuropsychiatric Disease and Treatment 2005:1(3) 196
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putative causal significance. Additionally, some of these
are normal morphologic variants that appear to be
overrepresented in schizophrenia (Smith et al 2003).
Generalized brain involvement in
schizophrenia: is it global or does
it follow a distinct pattern?
There is now convincing evidence of generalized (rather
than just selective) brain pathology in schizophrenia (Wright
et al 2000). Studies report diffuse cortical loss of tissue,
with gray matter being more selectively affected (Zipursky
et al 1992; Harvey et al 1993; Lieberman et al 1993;
Schlaepfer et al 1994; Kulynych et al 1995; Lim et al 1996;
Bagary et al 2003; Zhou et al 2003). Bagary and colleagues
(2003) have recently applied magnetic resonance transfer
imaging to study these gray–white matter changes in
schizophrenia. In a first-episode sample, they found
magnetization transfer signal loss especially in the frontal
cortex that did not appear to be associated with volume loss.
There is also recent use of diffusion tensor imaging (DTI),
which has the capacity to show subtle changes in white
matter structure and orientation (Frumin et al 2002). Such
technical developments are important because of the subtlety
and complexity of brain changes in schizophrenia. Wang
and colleagues (2004) conducted a study of DTI of the
cingulate gyrus in patients with schizophrenia. Amid
renewed interest in phospholipid abnormalities and deficits
in myelination in schizophrenia, DTI has emerged as a usual
neuroimaging approach to visualize white matter track
pathology. Wang and colleagues (2004) report a reduction
of left–right asymmetry in patients, as well as DTI deficits
(so-called lower fractional anisotropy: meaning less or less
integral white fibers which therefore create a lower
mathematical “signal”). This is yet another study showing
brain asymmetries in schizophrenia. Tim Crow, a leading
British schizophrenia researcher, believes that these
asymmetries are key to understanding the pathology of
schizophrenia, which he says relates to altered development
in the region of the brain subserving language (Crow 1989).
One possibility is that the diffuse loss is related to distinct
neural systems, of which the frontotemporal inter-
connections predominate. Pearlson and colleagues (1996)
have suggested that the brain changes in schizophrenia result
from diffuse involvement of (phylogenetically older)
Table 4 Neuroimaging studies: representative recent structural MRI studies in patients with first-episode schizophrenia
Nr of
Reference patients/controls Imaging focus Findings
Bagary et al 2003 30/30 Magnetic transfer imaging, Diffuse gray and white matter tissue loss 
whole brain MRI
Cahn et al 2002 34/36 Volumetric analysis, 7.7% lateral ventricular volume increase, 1.2% whole brain
whole brain volume decrease over 1 year; associated with poorer
outcome
Ho, Alicata, et al 2003 156 Volumetric analysis, Mean DUP of 74 weeks; DUP unrelated to brain or
whole brain neurocognitive abnormalities
Job et al 2002 34/36 Voxel based morphometrics,  Gray matter volume reductions in cingulate, ?frontal, and
whole brain temporal lobe structures
Kasai et al 2003b 13–15/14 Volumetric analysis, STG Progressive volume reduction of 9.6% in gray matter in
and hippocampus posterior STG and of 8.4% in anterior STG over 1.5 years in
first-episode schizophrenia
Keshavan et al 2002 31/31 Volumetric analysis, Selective regional reductions in corpus callosum
corpus callosum
Kim et al 2003 25/25 Volumetric analysis, STG Anterior and posterior STG decrements associated with
positive and negative symptoms, respectively
Kubicki et al 2002 16 and 16
a/18  Voxel-based morphometrics, Less STG reduction in bipolar vs schizophrenia patients
whole brain MRI
Smith et al 2003 33/19 Hippocampus Hippocampal fissure dilation, associated with poor
educational achievement
Sumich et al 2002 16/16 Volumetric analysis, Reductions in hippocampus (bilateral) and in planum
temporal lobe temporale (left)
a Sixteen patients with first-episode schizophrenia and 16 patients with first-episode affective psychosis.
Abbreviations: DUP, duration of untreated psychosis; STG, superior temporal gyrus.Neuropsychiatric Disease and Treatment 2005:1(3) 197
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heteromodal association cortex of frontal, temporal, and
subcortical regions. Buchanan and colleagues (2004)
recently examined these relationships in 44 patients with
schizophrenia. They found that patients had smaller inferior
prefrontal cortex volume than normal controls. In addition,
they showed a reversal of the normal asymmetry of the
inferior parietal cortex. Surprisingly, however, temporal lobe
volumes did not differ between patients and normal controls.
Another prevailing notion in structural neuroimaging of
schizophrenia is that schizophrenia is a disorder of neural
dysconnectivity (Andreasen, Flashman, et al 1994;
Andreasen 1999). To this end, abnormalities within the
cortico-striato-thalamo-cortical circuit have been suggested
in schizophrenia. Diminished volumes of thalamus, striatum,
and cortical gray matter have been described in neuroleptic-
naïve patients with schizophrenia (Lim et al 1996).
Myelinated fibers connecting these information-processing
centers have been reported to be swollen and to have
impaired integrity on DTI and magnetic transfer imaging
(Bagary et al 2003). Garver and colleagues (2004) have
sought to evaluate the effects of antipsychotic drugs and of
antipsychotic response upon volumetric change of both
cerebral white matter and gray matter associated with
thalamus, striatum, and cerebral cortex. Patients who had
responded had significant increases in thalamic and striatal
volumes, together with decreases in white matter volume
as compared with poor responders. Companion DTI in these
patients documented increased “integrity” (partial
normalization) of the impaired myelinated connections
among the information-processing centers. Cortical gray
matter increases were found only in patients treated with
atypical antipsychotics. The authors speculated that patients
who experienced antipsychotic responses during treatment
appear to have partial restoration of integrity of myelinated
connections among critical subcortical information-
processing centers, together with enhancement of thalamic
and striatal volumes. This is an interesting study showing
the evolution of this work as well as the complex interactions
between disease and medication (see Treatment response
and brain abnormalities).
Studies addressing cortical surface patterns in
schizophrenia are difficult to interpret, since there is such
great intersubject variation (Kulynych et al 1997; Kubicki
et al 2002). Also, detailed knowledge of normal anatomy of
cortical gyral patterns is at a rudimentary level. Nevertheless,
several studies have reported abnormalities of surface pattern
in schizophrenia (Kikinis et al 1994; Kulynych et al 1997;
Kubicki et al 2002; White et al 2003). It has been reported
that folding is less complex in the left hemisphere of gyral
patterns between patients and compared with normal
individuals. On the other hand, others have found diffuse
cortical dysmorphology in schizophrenia, which is most
pronounced in male patients. Sallet and colleagues (2003)
report on a large, well conducted MRI study of cortical
surface morphology wherein they found a 3%–4.5%
reduction in gyrification index (GI) – a measure of cortical
folding – in both hemispheres. This reduction in GI is more
prominent on the left side. The lack of differences in brain
volume between patients and controls in this study is
surprising. However, this strengthens the findings from this
study, since the evaluation of cortical morphology is
complicated by partial volume effects, incomplete
measurements across brain segments, and underlying
volumetric reductions. It is not clear, however, whether the
associations with clinical subtypes (disorganized subtype
had most GI reduction, paranoid subtype had least) have
any real relevance, even though the statistical strength of
these reported associations is robust. White and colleagues
(2003) found reduced cortical thickness and less curvature
in sulci (with greater curvature in gyri) in patients with early-
onset schizophrenia.
Ventricular enlargement
In broad terms, ventricular enlargement has been observed
more often than not in most studies, but the size of this effect
is small and, more speculatively, does not appear to be
confined to a subgroup of patients. Associations between
ventricular enlargement and illness chronicity have been
observed but these lack any consistency to support earlier
assertions that these CT abnormalities represented visual
proof of the dementia of dementia praecox. In a similar
manner, Crow’s Type I/Type II symptom and causal model
of schizophrenia, which predicted more brain abnormalities
in patients with chronic illness and with predominantly
negative symptoms, was not borne out in subsequent studies.
While ventricular enlargement is a replicable finding, it is
not generalized. There is evidence for third, but not fourth,
ventricular enlargement. Additionally, lateral ventricular
enlargement shows some regional specificity. Studies have
reported that the left temporal horn is selectively enlarged
in schizophrenia (and also, but to a lesser extent, in affective
disorder) (Crow 1989; Degreef et al 1992; McCarley et al
1999). Degreef and colleagues (1992) found that ventricular
enlargement was most pronounced in the frontal and
temporal horns (bilaterally), with enlargement of theNeuropsychiatric Disease and Treatment 2005:1(3) 198
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temporal horns associated with the presence of positive
symptoms. Morphometrics (the scientific study of form and
shape) has been applied in neuroimaging research in
schizophrenia. A study using morphometrics reported
prominent, gender-specific abnormalities of ventricular
shape in male patients with schizophrenia which were
localized to the foramen of Munro and the proximal portion
of the temporal horn of the lateral ventricular system
(Buckley et al 1999).
Regional brain abnormalities
There is evidence for brain changes in most, but not all,
regions selectively reported in imaging studies. This is
mostly prominent for the frontotemporal regions, the
thalamus, and the caudate nucleus (see sections below).
However, an area of intense research has been to determine
whether these focal/regional abnormalities are independent
of or in excess of more generalized cortical tissue loss.
Available evidence favors the latter assumption. Studies
addressing the brain regions that are most affected in
schizophrenia are reviewed below.
Temporal lobes
Since the publication of the earliest imaging studies in
schizophrenia (Johnstone et al 1989; Suddath et al 1989),
there has been an enduring focus on examining for temporal
lobe (gray and white matter) abnormalities. Several studies
report generalized temporal lobe reduction, selective
reductions in discrete structures, and subtle focal
asymmetries. Increasing technology has rendered this
analysis more complex with the sampling issues, technical
variation, definition of tissue boundaries, and variable
statistical power. The preponderance of evidence suggests
a loss of temporal lobe volume in schizophrenia of an order
of approximately 8% with comparable (or even slightly
larger) reductions when the amygdala or parahippocampal
gyrus are considered alone (Wright et al 2000; Csernansky
et al 2002). There is some evidence, but by no means
conclusive, that these losses show a predilection for the left
hemisphere. Studies report asymmetries within temporal
lobe structures, the planum temporale, Heschl’s gyrus, and
the superior temporal lobe gyrus (DeLisi et al 1994;
Kulynych et al 1995; Barta et al 1997; McCarley et al 1999;
Kesa et al 2003). Barta and colleagues (1997) have shown
reversed planum temporale asymmetry in schizophrenia,
with the right planum temporale surface area being greater
so that gray matter volume is reduced in patients relative to
controls. This results from substantial loss in thickness of
planum temporale gray matter in the right hemisphere of
patients with schizophrenia. They have also shown that
smaller superior temporal lobe volume is associated with
auditory hallucinations in schizophrenia (Barta et al 1990).
Shenton and colleagues (1992) reported similar associations
for thought disorder in patients with schizophrenia. Recently,
Kasai and colleagues (2003a) have reported substantial
decreases in gray matter volume in the left Heschl’s
gyrus and left planum temporale among first-episode
schizophrenia patients who were imaged twice over a
1.5-year span. Importantly, this pattern was not seen among
the psychotic control group of first-episode affective
psychoses. Turetsky and colleagues (2003) have examined
whether the anterior temporal lobe deficits observed in
imaging studies might be associated with impairments in
olfactory function in patients with schizophrenia. Among
52 patients, they found evidence that reduction in anterior
ventromedial (but not entorhinal) temporal lobe volume was
related to olfactory dysfunction. Csernansky and colleagues
(1998, 2002) noted shape changes in the hippocampus in
patients with schizophrenia that was not attributable to focal
tissue loss in the hippocampus.
Frontal lobes
The frontal lobes have also been the subject of extensive
structural imaging research. Andreasen and colleagues
(1986, 1990), in a seminal study, showed marked frontal
lobe decrements on MRI. Many subsequent studies, but not
all, have noted a modest (6%–8%) volumetric reduction.
The complexity of the gyral pattern in the frontal cortex has
made standardization of subregions difficult, and different
researchers have applied disparate criteria to determine the
boundaries for this region. More recently, Roth and
colleagues (2004) examined the relationships between
apathy in patients with schizophrenia and structural and
cognitive brain changes. They observed that only patients
with high apathy scores exhibited decrements in frontal lobe
volume.
Caudate nucleus
An accumulating literature also points to abnormalities in
caudate and related regions that may be related to treatment
effects. Jernigan and colleagues (1991) reported caudate
nucleus enlargement in patients with schizophrenia but its
meaning was unclear until later studies found that caudate
size depended on whether patients were receiving treatment
with typical or atypical antipsychotic medications (Breier
et al 1992; Chakos et al 1994; Keshavan et al 1994, 2002).Neuropsychiatric Disease and Treatment 2005:1(3) 199
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It was noted that the caudate volume decreased in patients
who were changed from treatment with typical anti-
psychotics to clozapine therapy. This effect has also been
observed (although is less pronounced) with other atypical
antipsychotics. Dazzan and colleagues (2004) investigated
the effect of antipsychotic medications on brain structure
in 90 patients at their first psychotic episode. Of these,
50 patients were taking typical neuroleptics, 16 were taking
atypicals, and 24 were drug-free. These results highlighted
that, in comparison to drug-free subjects, those on typical
neuroleptics showed larger gray matter volume of basal
ganglia and smaller gray matter volume of the right insula
and bilateral precuneus. In contrast, patients taking only
atypical neuroleptics, compared with drug-free subjects,
showed larger gray matter volume of the thalamus
(bilaterally). This study illustrated that even the short-term
use of typical neuroleptics is associated with basal ganglia
and cortical volume changes. Lang and colleagues (2004)
reported on a study where patients were switched from either
older antipsychotics or risperidone to olanzapine. The effect
on brain structures of switching from older drugs to
olanzapine was greater than for the switch from risperidone
to olanzapine. Putamen and globus pallidus volumes were
significantly reduced in switching from older drugs to
olanzapine. In an outpatient sample of patients with a longer
duration of illnesses, Arango and colleagues (2003) also
found a differential effect of medication treatment and
response associated with structural abnormalities. Patients
with larger, more preserved, brain volume were more likely
to respond to clozapine. This was not true for patients who
were treated with haloperidol.
Thalamus
There has been much interest in thalamic volume in the light
of the theory of neural dysconnectivity in schizophrenia.
Subtle decrements in thalamic volume have also been
reported which are consistent with the fundamental role of
the thalamus as a cortical–subcortical relay station and with
findings of thalamic hypometabolism in schizophrenia. In
a study that used a bounding box approach to create an
average thalamus, Andreasen, Arndt, and colleagues (1994)
reported a reduction in thalamic volume in schizophrenia.
Kemether and colleagues (2003) recently performed high
resolution MRI examining substructure volumes of the
thalamus in 41 patients with schizophrenia. The most
pronounced volume decrements were seen in the
mediodorsal and pulvinar nuclei of the thalamus. This was
not attributable to a medication effect, since the same pattern
was seen among a subsample of 15 patients in this study
who had never been treated with antipsychotic medications.
In another analysis from the same study, these volume losses
were associated with the ventricular enlargement (Gaser et
al 2004). Although conclusions from correlation analyses
should be limited, the authors asserted that these thalamic
losses may in part explain the extent of ventricular
enlargement in schizophrenia. In a complementary study
from Japanese investigators, decreased volume of the
anterior portion of the internal capsule was seen among
53 patients with schizophrenia, which the authors attributed
to a possible effect upon adjacent thalamic structures (Zhou
et al 2003).
Corpus callosum
There is an extensive but largely confusing literature
documenting an array of size and shape changes in the
corpus callosum in patients with schizophrenia (Woodruff
et al 1995; Wright et al 2000; Keshavan et al 2002). A
landmark-based analysis of midsagittal structures in
14 patients and 14 normal controls reported focal
displacement, reduced thickness of the corpus callosum, and
displacement of adjacent upper brain stem structures in
schizophrenia (DeQuardo et al 1996). Thus far, it has been
difficult to image the corpus callosum in detail and to
synthesize findings across studies (many of which are of
small sample size).
Cerebellum
The cerebellum has been a recent focus of research because
of the proposed disruption of cortico-cerebellar-thalamic-
cortical networks that might lead to cognitive dysmetria in
schizophrenia (Andreasen 1999). In general, however, the
preponderance of studies do not find cerebellar
abnormalities in schizophrenia. However, a few studies have
shown selective cerebellar hypoplasia (Aylward et al 1994).
Ho and colleagues (2004) showed smaller cerebellar volume
in first-episode schizophrenia patients who exhibited
cerebellar neurological soft signs. Structural imaging finds
of cerebellar abnormalities in schizophrenia are scant.
Clinical correlates of structural
brain abnormalities in
schizophrenia
Gender-specific findings
Structural brain abnormalities occur more frequently and
are more pronounced in male patients with schizophreniaNeuropsychiatric Disease and Treatment 2005:1(3) 200
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(Kulynych et al 1995; O’Callaghan et al 1995; Frazier et al
1996; Lim et al 1996; McCarley et al 1999; Weinberger and
Marenco 2003). This is in accordance with epidemiologic
observations and also with the belief that male patients
with schizophrenia are more likely to express neuro-
developmental process(es) (Jones and Buckley 2003).
Symptoms
Association with symptoms, however, is more complex.
Temporal lobe abnormalities have been associated with
positive symptoms (Barta et al 1990; Shenton et al 1992;
Turetsky et al 1995; Ho, Andreasen, et al 2003; Kim et al
2003; Flashman and Green 2004). Similarly, negative
symptoms of schizophrenia have been shown to be
associated with subtle tissue decrements in the frontal lobes
(Andreasen et al 1990; Breier et al 1992; Buchanan et al
1993; Turetsky et al 1995; Lim et al 1996; Chua et al 1997;
Ho, Andreasen, et al 2003; Flashman and Green 2004; Roth
et al 2004). These are difficult to interpret because of the
methodologic issues of imaging, often small samples, and
the inherent risk of Type I error when correlations are sought
between anatomic structures and multiple clinical measures
(Turetsky et al 1995; Sallet et al 2003). Additionally, in the
absence of longitudinal assessments, studies are difficult to
replicate, since they rely upon symptom complexes that may
not be stable over time. Narr and colleagues (2003) report
on a highly complicated but very interesting study from an
international (US–UK) collaborative group. The findings
of more progressive cerebrospinal fluid (CSF) increases in
patients with schizophrenia who are younger is consistent
with emerging evidence that brain changes in schizophrenia
are not static. The authors argue that cortical tissue loss is
more subtle and, therefore, while they report CSF increases
they cannot discount accompanying cortical volume
reductions. This may well be so, but the tissue volume
reductions are estimated at about 5% and have been
generally reproducible in modern MRI studies. The
authors, by way of explanation, provide an account of the
differences between their computational landmark-based
morphometrics and other voxel-based morphometric
approaches. The effects of age and gender upon CSF volume
and cortical gray matter changes are carefully teased out
here. Young male patients with schizophrenia are most
affected; this is consistent with other gender-specific
findings (see above). In another 5-year follow-up study,
Milev and colleagues (2003) found that persistence of
auditory hallucinations over 5 years of care was associated
with smaller temporal lobe volumes bilaterally.
Genes and brain abnormalities
Genetic influences on brain abnormalities in schizophrenia
have also been extensively studied (Suddath et al 1990;
Frangou et al 1997; Lawrie et al 1999; McCarley et al 1999;
Stefanis et al 1999; Siedman et al 2003; Tepest et al 2003).
Several studies of high-risk families report a pattern of
structural abnormalities in relatives that is broadly similar
to, but less pronounced than that of affected probands
(Frangou et al 1997; Johnstone et al 2002; Siedman et al
2003). The seminal MRI study of monozygotic twins
discordant for schizophrenia showed that twins affected with
schizophrenia had ventricular enlargement and temporal
lobe abnormalities that were not seen in their normal co-
twins (Suddath et al 1990). These findings have been
extended and replicated (Siedman et al 2003). The
interaction between genes and environment has also been
studied. It has been found that the genetic effects may relate
to cortical pathology, while ventricular enlargement may
be related to obstetric complications.
The Edinburgh high-risk study has elegantly addressed
this “graded effect” of genetic risk (Lawrie et al 1999).
Asymptomatic offspring from high-risk families had smaller
temporal lobe structures than control individuals. The
offspring who went on to show psychotic symptoms also
had smaller whole brain volumes than the nonpsychotic
offspring (Lawrie et al 1999; Johnstone et al 2002). Siedman
and colleagues (2003) also show a strong relationship
between genetic loading for schizophrenia and temporal lobe
abnormalities. Tepest and colleagues (2003) also report
subtle deformations of hippocampal shape as well as volume
reductions in patients and in their “unaffected” relatives
when compared with normal controls. Tepest and colleagues
(2004) also measured thalamus volume and shape in patients
and healthy siblings to study the changes as a marker of
genetic vulnerability for schizophrenia in 13 pairs of patients
with schizophrenia and their unaffected siblings from
families with multiple affected members, in 12 patients with
schizophrenia from families without another affected
member, and in 10 healthy controls. Thalamus volume and
shape were compared using large-deformation high-
dimensional brain mapping. The researchers observed a
decrease in thalamic volume (6%), covaried for total cerebral
volume, in the schizophrenia subjects without affected
members in their families. In patients from families that
were multiply affected by the illness, the investigators also
found a minor decrease of the volume (2%). Healthy family
members showed no volume reduction of the thalamus.
These findings contrast with the finding in the hippocampus,Neuropsychiatric Disease and Treatment 2005:1(3) 201
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wherein hippocampal volume and shape were changed in
healthy and ill members from multiply affected families in
a similar way to those in schizophrenic patients from families
without a history of the illness. There is even evidence of
more subtle (but nevertheless similar) abnormalities in the
brains of patients who are genetically at high risk for
developing schizophrenia. Two recent sequential MRI
studies in ultra high-risk patient groups provide preliminary
evidence of reduction in temporal lobe structures in patients
who convert from high risk to actual schizophrenia (Lawrie
et al 2001; Pantelis et al 2003). Another genetic variant of
schizophrenia is schizotypal personality disorder (SPD).
Recently, Dickey and colleagues (2003) failed to replicate
their earlier finding of smaller left superior temporal gyrus
volume in SPD patients. They did, however, find greater
temporal gyrus asymmetry in patients who also had a family
history of mental illness. Siever and Davis (2004) highlight
the degree of overlap in psychophysiological deficits (eg,
impaired sensory gating, prepulse inhibition deficits, poor
performance on attention tasks, and overall similarity of
brain structure changes – more attenuated findings except
for relative preservation of frontal lobe volume in SPD)
between chronic schizophrenia and SPD. They suggest a
model wherein social and cognitive deficits predominate as
the clinical expression of genetic vulnerability that
selectively affects frontal and temporal lobe structures. The
extent, then, to which patients are “spared” and go on to
develop SPD rather than schizophrenia depends on the extent
of modifying factors (eg, frontal reserve capacity, general
intelligence) and the extent of the individual’s risk factors
and the proposed genetic–environmental interactions.
Another approach in studying the genetic influence upon
brain structure in schizophrenia is to study genetic
phenocopies of schizophrenia (McDonald and Murphy
2003). Velocardiofacial syndrome (VCFS) is the prototype,
as it is associated with high rates of psychosis. Brain
changes, similar to but more attenuated than those in
schizophrenia have been observed in VCFS; a recent DTI
study showed white matter changes in this condition
(Barnea-Goraly et al 2003).
Minor physical anomalies and
neuroimaging
Minor physical anomalies (MPAs) are commonly found in
elevated frequency among patients with schizophrenia,
providing evidence to support the neurodevelopmental
hypothesis (Buckley et al 2003). Dean and colleagues (2004)
examined the relationship between the presence of minor
physical anomalies and brain morphology (MRI) in 60 first-
episode psychosis patients, divided into two groups (high
and low MPA groups each with 30 patients). In comparison
with the low MPA group, patients with high MPAs showed
larger gray matter volume of basal ganglia (bilateral),
thalamus (bilateral), inferior temporal gyrus (right), lingual
gyrus (bilaterally), and cuneus (right). They also showed
smaller gray matter volume at the level of the lobulus
paracentralis (bilaterally), with extension anteriorly into the
dorsal frontal gyrus, posteriorly into the precuneus, and
inferiorly into the cingulate gyrus (left). The authors
concluded that high MPA frequency was associated with
gray matter volume changes on MRI even in first-episode
psychosis.
Treatment response and brain
abnormalities
Response to neuroleptic treatment has also been examined
in relation to neuroimaging abnormalities (Friedman et al
1991; Lieberman et al 1992; Kikinis et al 1994; Ho,
Andreasen, et al 2003). Kolakowska and colleagues (1985)
reported that cortical atrophy on CT was associated with
poor treatment outcome. Lieberman and colleagues (1993),
in a first episode of schizophrenia study, found that a global
index of brain abnormalities chiefly reflecting ventricular
enlargement (but not any cortical and temporal lobe
pathology) predicted treatment response. In contrast,
Friedman and colleagues (1991) reported that prefrontal
sulcal prominence was inversely related to clozapine
response. They postulated that this tissue loss resulted in
diminished response to clozapine owing to a decrement in
frontal serotonergic receptors. Neuroimaging studies have
shown that typical neuroleptics may increase volume,
metabolism, and relative blood flow in the basal ganglia,
and that these actions can be reverted or not apparent with
atypical antipsychotics (Liddle and Pantelis 2003). Effects
of medication on the basal ganglia have been described
above. The different effects of neuroleptics upon brain
structure remain poorly understood. Patients at their first
psychotic episode represent an ideal sample to investigate
differential effects of neuroleptics on brain structure, as the
study described earlier (Dazzan et al 2004) illustrates.
Interesting findings have also emerged from a comparative
study of olanzapine and haloperidol in first-episode
schizophrenia during which patients receive sequential
neuroimaging assessments (Lieberman et al in press). Over
the course of 1 year, patients on haloperidol showed a
divergent pattern on MRI compared with patients beingNeuropsychiatric Disease and Treatment 2005:1(3) 202
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treated with olanzapine, with patients treated with
haloperidol showing loss of gray and white cortical matter,
as well as enlarged ventricular volume. The possible
“sparing” of progressive brain changes in patients treated
with olanzapine is a noteworthy and intriguing finding.
Patients treated with olanzapine also had greater
improvement in cognitive function over the first year of
treatment. Ho, Andreasen, and colleagues (2003) also found
worsening of brain changes in patients who were receiving
treatment with first-generation antipsychotics compared
with patients on newer, second-generation agents. The
therapeutic implications of such studies for the selection of
second-generation antipsychotic medications over first-
generation antipsychotics are important and compelling.
This is also of therapeutic interest because many researchers
believe that failure to intervene early (and aggressively)
when schizophrenia first begins may result in the illness
running a more unfavorable long-term course (Harrigan et
al 2003). The findings from first-episode brain imaging
underscore this notion, since even at the earliest stages of
illness there is evidence of prominent brain changes. The
recent seminal study by Thompson and colleagues (2001)
is a good example and it showed progressive cortical
tissue loss in childhood schizophrenia. A summary of
representative first-episode brain imaging studies is given
in Table 4. Additionally, there is some, albeit preliminary,
evidence that second-generation antipsychotic medications
may help “recovery” of brain cells (ie, stimulate neuro-
genesis), an effect that is not seen with older, first-generation
medications (Wake et al 2002). Taken collectively, these
observations provide the context for early intervention
studies seeking to evaluate the prodrome of schizophrenia
(Pantelis et al 2003) and seeking to avert/abort/delay the
onset of schizophrenia (McGlashan et al 2003).
Concluding remarks
There is now compelling evidence from neuroimaging
studies that schizophrenia is a brain disease. Abnormalities,
albeit subtle in magnitude and variable in extent across
studies, are now reported in virtually every brain region;
global deficits, lateral ventricular enlargement, and
frontotemporal deficits are the most pronounced. It is still
unclear as to the relationship of these changes to associations
with illness and clinical variables, and these brain changes
have yet to directly affect clinical care. Even though the
observations of structural changes and progressive tissue
loss on neuroimaging are provocative, they are not yet of
clinical or diagnostic relevance.
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